# "Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"

> **NCT03929419** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 29 (actual)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **DRUG:** intranasal insulin
- **DRUG:** Placebo spray

## Key facts

- **NCT ID:** NCT03929419
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-21
- **Primary completion:** 2021-03-25
- **Final completion:** 2021-04-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03929419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03929419, ""Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03929419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*